Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
GLENMARK PHARMACEUTICALS LTD. - Board recommends Dividend
Download < Back
27 Jun 2020
Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 26, 2020, inter alia, has recommended Dividend @ 250% i.e. Rs. 2.50/- per share (face value of Re. 1/- each) on the Equity Share Capital of the Company for the financial year 2019 - 20 subject to the approval of the Shareholders at the ensuing Annual General Meeting.
View all announcements for GLENMARK PHARMACEUTICALS LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips